对于BCS III药物的口服药物输送系统的最新进展
Junpeng Yu1, Peng Wang1, Zishen Bei1
1Institute of Traditional Chinese Medicine Zhuang-Yao Medicine Research, Guangxi University of Chinese Medicine, Nanning 530200, China.
Current issues in molecular biology
|January 30, 2026
概括
生物制药分类系统 (BCS) 第三类药物由于肠道透性低,口服吸收不佳. 本综述分析了增强口服生物可用性的策略,强调了有效药物递送系统需要以机制为导向的选择.
科学领域:
- 药理学 药理学是指药理学的学科.
- 药物运输 药物运输 药物运输
- 生物制药生物制药公司
背景情况:
- 生物制药分类系统 (BCS) III类药物具有高溶解性,但肠道透性较低.
- 这一特征限制了口服生物可用性,独立于溶解速度,由于肠道吸收障碍和个体间的变化.
研究的目的:
- 批判性地评估提高BCS III类药物的口服生物利用率的策略.
- 用肠道透性屏障作为框架来分析口服吸收的关键决定因素.
主要方法:
- 文献综述,重点关注肠道透性屏障.
- 基于机制,疗效,条件和可行性的生物可用性增强策略的比较分析.
主要成果:
- 确定了各种生物可用性增强策略的内在限制和边界.
- 证明没有一个单一的策略可以普遍克服BCSIII类药物的吸收障碍.
结论:
- 以机制为指导的策略选择对于口服药物输送系统的合理设计至关重要.
- 为开发针对BCS III类药物量身定制的口服输送系统提供了基础.
相关概念视频
Drug Delivery: Overview
844
The selection of a drug's delivery route depends upon its physicochemical properties, including lipid or water solubility and ionization, as well as the therapeutic requirement, such as immediate or sustained effect. These routes can be divided into three primary categories: enteral, parenteral, and topical.
Enteral delivery involves administering drugs directly through swallowing, sublingual placement, or buccal application. Orally administered drugs predominantly navigate the...
Enteral delivery involves administering drugs directly through swallowing, sublingual placement, or buccal application. Orally administered drugs predominantly navigate the...
844
Non-Oral Extravascular Drug Absorption Routes
523
Non-oral extravascular routes, which encompass sublingual, buccal, topical, intramuscular, and inhalation methods, primarily utilize passive diffusion to transport drugs into the systemic circulation. The absorption rates and effectiveness of these routes depend on the drug's physicochemical properties, as well as the patient's anatomical and pathophysiological state.
Lipophilic drugs that are stable at salivary pH (6) and exhibit minimal binding to the oral mucosa are absorbed more...
Lipophilic drugs that are stable at salivary pH (6) and exhibit minimal binding to the oral mucosa are absorbed more...
523
Drug Delivery: Enteral Route
1.7K
The enteral drug administration involves three primary routes: oral, sublingual, and buccal. Oral ingestion is the most prevalent, safe, economical, and convenient method for drug administration. However, it has certain drawbacks, including limited absorption due to the drug's low water solubility or poor membrane permeability, possible emesis from GI mucosa irritation, destruction of drugs by digestive enzymes or low gastric pH, and irregular absorption along with food or other drugs.
1.7K
Drug Delivery: Parenteral Route
1.7K
The parenteral route is a critical method of drug administration. It delivers compounds directly into the systemic circulation and bypasses the gastrointestinal tract. This approach is particularly advantageous for drugs that exhibit poor absorption or instability when administered orally.
There are three primary parenteral routes: intravenous (IV), intramuscular (IM), and subcutaneous (SC). The IV route introduces the drug directly into the bloodstream, ensuring immediate action. The IM route...
There are three primary parenteral routes: intravenous (IV), intramuscular (IM), and subcutaneous (SC). The IV route introduces the drug directly into the bloodstream, ensuring immediate action. The IM route...
1.7K
Drug Delivery: Miscellaneous Routes
814
Drug delivery methods like oral inhalation, nasal sprays, transdermal patches, eye drops, intravitreal injection, and rectal administration provide localized effects with reduced toxicity.
Oral inhalation and nasal sprays swiftly transfer drugs across the respiratory epithelium's mucosal layer. Inhaled glucocorticoids and bronchodilators directly target lung conditions such as asthma, while fluticasone nasal spray mitigates allergic rhinitis.
Transdermal patches transport drugs...
Oral inhalation and nasal sprays swiftly transfer drugs across the respiratory epithelium's mucosal layer. Inhaled glucocorticoids and bronchodilators directly target lung conditions such as asthma, while fluticasone nasal spray mitigates allergic rhinitis.
Transdermal patches transport drugs...
814
Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants
2.3K
Oral anticoagulants are vital tools in preventing and treating blood clotting disorders. This diverse class of medications can be categorized as vitamin K antagonists, exemplified by warfarin, and direct thrombin inhibitors (DTIs), such as dabigatran, as well as factor Xa inhibitors, including rivaroxaban.
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
2.3K


